Black Bird Biotech, Inc.
BBBT
Get informed when a big investor buys or sells
+ FollowMarket Cap$98.41K
Close$
Share Statistics
| Market cap | $98,405.00 |
|---|---|
| Enterprise Value | $840,783.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 1.95 |
| Outstanding Shares | 1,456,744,052 |
Return
| Return on Equity | 110.58% |
|---|---|
| Return on Assets | -1033.01% |
| Return on Invested Capital | 34.15% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | 0.04 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 23.15 |
| Enterprise Value to EBIT | -2.68 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.89 |
| Debt to Equity | -0.81 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Black Bird Biotech, Inc.
4 employees
CEO: Nelson Grist Black Bird Biotech Inc. operates within the biotechnology sector, offering a diverse array of products. A key offering is MiteXstream, a unique plant-derived biopesticide manufactured and distributed by the company, specifically formulat...